TUMOR PROFILING FOR TRANSLATIONAL & CLINICAL RESEARCH
MERCURY’s intuitive interface enables user to quickly visualize a precise and complete molecular tumor profile for cancer patients following the rapid analysis of their sequencing data (tumoral DNA and RNA plus constitutional DNA).
MERCURY also provides users access to numerous annotation databases, links to potential clinical trials and treatment options based on identified variants, and the ability to create and export a customizable report.
TRANSFORMING SEQUENCING DATA INTO KNOWLEDGE
MERCURY™ is now customizable for large and small gene panels
MERCURY is now fully adaptable to your data analysis needs with the ability to manage oncology sequencing data ranging from broad sequencing (WES, RNA-Seq, WGS) to large gene panels and down to targeted gene panels. Whether you use an off the shelf 3rd party panel or have developed your own, IntegraGen will work with you to customize the data analysis pipeline and reporting for the clinical sequencing you perform.
Click here to view Mercury’s user interface
For Research Use Only. Not for use in diagnostic procedures.